SGEN - Seattle Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue418,147336,802286,758
Cost of Revenue42,31737,44029,058
Gross Profit375,830299,362257,700
Operating Expenses
Research Development379,308294,529230,743
Selling General and Administrative139,247125,783104,320
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-142,725-120,950-77,363
Income from Continuing Operations
Total Other Income/Expenses Net2,6144641,222
Earnings Before Interest and Taxes-140,111-120,486-76,141
Interest Expense---
Income Before Tax-140,111-120,486-76,141
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-140,111-120,486-76,141
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-140,111-120,486-76,141
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-140,111-120,486-76,141